ArticleEpidemiology and infection2021
The spatio-temporal distribution of COVID-19 infection in England between January and June 2020.
Article in Epidemiology and infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Spatio-Temporal COVID-19 Modeling: A Global Systematic Review of Data Integration, Equity, and Lessons for Pandemic Preparedness.International journal of environmental research and public health · 2026Pooled it
- Did COVID-19 surveillance system sensitivity change after Omicron? a retrospective observational study in England.BMC infectious diseases · 2025Observational
- The impact of health inequity on spatial variation of COVID-19 transmission in England.PLoS computational biology · 2024Article
- Infectious Disease in the Workplace: Quantifying Uncertainty in Transmission.Bulletin of mathematical biology · 2024Article
- Understanding spatiotemporal patterns of COVID-19 incidence in Portugal: A functional data analysis from August 2020 to March 2022.PloS one · 2024Article
- Structural Inequality and COVID-19 Mortality in Chicago: An Ecological Analysis.Journal of racial and ethnic health disparities · 2023Article
- Exploring the spatio-temporal clusters of closed restaurants after the COVID-19 outbreak in Seoul using relative risk surfaces.Scientific reports · 2023Article
- Spatio-temporal evolution of COVID-19 in the Republic of Ireland and the Greater Dublin Area (March to November 2020): A space-time cluster frequency approach.Spatial and spatio-temporal epidemiology · 2023Article
- Exploring the Spatial Relative Risk of COVID-19 in Berlin-Neukölln.International journal of environmental research and public health · 2023Article
- Identifying obesity and COVID-19 overlapping risk-factors: Protocol for a systematic review and meta-analysis.Journal of public health research · 2022Article
- Dynamic Demand Evaluation of COVID-19 Medical Facilities in Wuhan Based on Public Sentiment.International journal of environmental research and public health · 2022Article
- An analysis of the dynamic spatial spread of COVID-19 across South Korea.Scientific reports · 2022Article
- Measurement of contagion spatial spread probability in public places: A case study on COVID-19.Applied geography (Sevenoaks, England) · 2022Article
- The Geographical Distribution and Influencing Factors of COVID-19 in China.Tropical medicine and infectious disease · 2022Article
- Spatial Dynamics and Multiscale Regression Modelling of Population Level Indicators for COVID-19 Spread in Malaysia.International journal of environmental research and public health · 2022Article
- The correlation between attack rates and urban health indicators during the third wave of the COVID-19 outbreak in Turkey.Frontiers in public health · 2022Article
- Exploring the effects of PMEnvironmental research · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The spatio-temporal dynamics of an outbreak provide important insights to help direct public health resources intended to control transmission. They also provide a focus for detailed epidemiological studies and allow the timing and impact of interventions to be assessed.A common approach is to aggregate case data to administrative regions. Whilst providing a good visual impression of change over space, this method masks spatial variation and assumes that disease risk is constant across space. Risk factors for COVID-19 (e.g. population density, deprivation and ethnicity) vary from place to place across England so it follows that risk will also vary spatially. Kernel density estimation compares the spatial distribution of cases relative to the underlying population, unfettered by arbitrary geographical boundaries, to produce a continuous estimate of spatially varying risk.Using test results from healthcare settings in England (Pillar 1 of the UK Government testing strategy) and freely available methods and software, we estimated the spatial and spatio-temporal risk of COVID-19 infection across England for the first 6 months of 2020. Widespread transmission was underway when partial lockdown measures were introduced on 23 March 2020 and the greatest risk erred towards large urban areas. The rapid growth phase of the outbreak coincided with multiple introductions to England from the European mainland. The spatio-temporal risk was highly labile throughout.In terms of controlling transmission, the most important practical application of our results is the accurate identification of areas within regions that may require tailored intervention strategies. We recommend that this approach is absorbed into routine surveillance outputs in England. Further risk characterisation using widespread community testing (Pillar 2) data is needed as is the increased use of predictive spatial models at fine spatial scales.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.